Snap Q4 Revenue Beats as Advertising Rebounds, but User Growth Misses Expectations
Snapchat parent Snap reports Q4 revenue of $1.72 billion and net income of $45 million, but daily active users of 474 million fall short of 477 million estimate.
3055 articles found for "investing"
Qualcomm Stock Slides Despite Record Quarter as Global Memory Shortage Clouds Outlook
Qualcomm posts record Q1 revenue of $11.3 billion but shares tumble 5% as memory shortage forces weak Q2 guidance, dimming smartphone market outlook.
Alphabet Unleashes $175 Billion AI Spending Blitz as Q4 Revenue Tops $113 Billion
Google parent Alphabet reports record Q4 2025 earnings with $113.8 billion revenue and announces $175-185 billion in 2026 CapEx for AI infrastructure.
Amgen Surges 7% as Q4 Earnings Beat and Weight-Loss Drug Pipeline Offset Sector Gloom
Amgen stock jumps 7% after reporting Q4 earnings that crushed estimates with $5.29 EPS versus $4.73 expected, as the biotech giant's weight-loss drug ambitions gain traction.
Yum Brands Q4 Earnings: Taco Bell Powers 7% Same-Store Growth While Pizza Hut Struggles
Taco Bell delivers exceptional 7% same-store sales growth in Q4 2025 as Yum Brands reports mixed results with KFC steady and Pizza Hut continuing to underperform.
Match Group Beats Q4 Estimates as Hinge Growth Powers Dating App Turnaround
Match Group reported Q4 revenue of $878 million, beating estimates as Hinge revenue surged 26%. The Tinder parent raised its dividend 5% and expects free cash flow of $1.1 billion in 2026.
UBS Beats Q4 Expectations, Announces $3 Billion Buyback as Integration Progresses
UBS reported Q4 profit of $1.2 billion, beating estimates by 31%, and announced $3 billion in share buybacks for 2026. Assets under management exceed $7 trillion for the first time.
Meta Cuts 1,500 Reality Labs Jobs as Zuckerberg Abandons Metaverse Dream for AI
Meta is laying off 10% of its Reality Labs division—about 1,500 employees—as CEO Mark Zuckerberg pivots the company's focus from virtual reality to artificial intelligence.
AbbVie Beats Q4 Estimates as Skyrizi and Rinvoq Revenues Soar Past Humira's Decline
AbbVie delivers better-than-expected Q4 2025 earnings as immunology blockbusters Skyrizi and Rinvoq more than offset the biosimilar erosion of former cash cow Humira.
Chip Sector's Super Wednesday: Alphabet, Qualcomm, and Arm Prepare for Pivotal Earnings
Alphabet, Qualcomm, and Arm Holdings all report Q4 earnings after Wednesday's close in a pivotal test for AI infrastructure spending and semiconductor demand.
Eli Lilly Delivers Blockbuster Q4 as Mounjaro and Zepbound Power 23% Revenue Surge
Eli Lilly reports Q4 2025 earnings that beat Wall Street estimates as its blockbuster weight-loss drugs Mounjaro and Zepbound continue to dominate the GLP-1 market.
Software Selloff Goes Global: Asian Tech Stocks Plunge as AI Disruption Fears Cross Oceans
Japanese IT giant TIS crashes 15%, Indian IT stocks drop 6%, and Chinese software plunges 15% as Wall Street's AI disruption fears spread to Asia overnight.